Application Nr Approved Date Route Status External Links
NDA021313 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Clarinex-D 12 Hour Is A Combination Product Containing A Histamine-1 (H1) Receptor Antagonist And An Alpha Adrenergic Agonist Indicated For: Relief Of Nasal And Non-Nasal Symptoms Of Seasonal Allergic Rhinitis, Including Nasal Congestion, In Adults And Adolescents 12 Years Of Age And Older. ( 1.1 ) 1.1 Seasonal Allergic Rhinitis Clarinex-D ® 12 Hour Extended Release Tablets Is Indicated For The Relief Of The Nasal And Non-Nasal Symptoms Of Seasonal Allergic Rhinitis, Including Nasal Congestion, In Adults And Adolescents 12 Years Of Age And Older. Clarinex-D 12 Hour Extended Release Tablets Should Be Administered When The Antihistaminic Properties Of Desloratadine And The Nasal Decongestant Properties Of Pseudoephedrine Are Desired [See Clinical Pharmacology (12) ].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments